Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Nilsson, , Khalid,
DOB: 10-APR-1952 (Age: 73)
Gender: male
Address:
Gengränd 482
691 31 Karlskoga (Sweden)
ID: 8339-594203-6 (ECI)
Report
Date: 22-AUG-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Karlskoga Lasarett
691 31 Karlskoga (Sweden)
Specimen
Collected: 21-AUG-2017

Chemistry

Test 22-AUG-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 91.0 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 12.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.6 - 10.2 mg/dL
Sodium [Moles/volume] in Blood 140.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.7 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.7 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured laboratory values are within normal limits for this patient, including glucose metabolism, renal function, and electrolyte balance. No laboratory abnormalities detected; results are unremarkable from a clinical laboratory perspective. Continued routine monitoring is recommended.